.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Dow
Fuji
Accenture
Harvard Business School
UBS
Healthtrust
Cipla
AstraZeneca

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202015

« Back to Dashboard
NDA 202015 describes YAELA, which is a drug marketed by Novast Labs Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the YAELA profile page.

The generic ingredient in YAELA is drospirenone; ethinyl estradiol. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.

Summary for 202015

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202015

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
YAELA
drospirenone; ethinyl estradiol
TABLET;ORAL-28 202015 ANDA Nivagen Pharmaceuticals, Inc. 75834-115 75834-115-29 3 BLISTER PACK in 1 CARTON (75834-115-29) > 1 KIT in 1 BLISTER PACK
YAELA
drospirenone; ethinyl estradiol
TABLET;ORAL-28 202015 ANDA Nivagen Pharmaceuticals, Inc. 75834-115 75834-115-84 1 BLISTER PACK in 1 PACKET (75834-115-84) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength3MG;0.03MG
Approval Date:Nov 19, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Medtronic
Deloitte
Cantor Fitzgerald
Accenture
Julphar
Daiichi Sankyo
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot